Summary
A progressive rise in arterial calcium content is the most characteristic age-associated alteration in the arterial wall and the decisive factor in arteriosclerotic degeneration. Experimental studies have demonstrated that calcium antagonists can prevent or retard the development of arterial calcinosis associated with vitamin D overload, hypertension or alloxan-induced diabetes. Although similar effects are more difficult to observe in humans, they have been demonstrated in patients with coronary artery disease and in patients with end-stage renal disease, which is characterised by an acceleration of the normal arterial aging process.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Blumenthal HT, Lansing AI, Wheeler PA. Calcification of the media of the human aorta and its relation to intimai arteriosclerosis, ageing, and disease. American Journal of Pathology 20: 665–671, 1944
Fleckenstein A. Calcium antagonism: history and prospects for a multifaceted pharmacodynamic principle. In Opie LH (Ed.) Calcium antagonists and cardiovascular disease, pp. 9–28, Raven Press, New York, 1984
Ibels SL, Alfrey AC, Huffer WE, Craswell PW, Anderson JT, et al. Arterial calcification and pathology in uremic patients undergoing dialysis. American Journal of Medicine 66: 790–796, 1979
Lichtlen PR, Hugenholtz PG, Fafflenbeul W, Hecker H, Jost S, et al. Retardation of angiographic progression of coronary artery disease by nifedipine. Results of the Nifedipine International Trial on Antiatherosclerotic Therapy (INTACT). Lancet 335: 1109–1113, 1990
London GM, Marchais SJ, Guerin AP, Metivier F, Safar ME, et al. Salt and water retention and calcium blockade in uremia. Circulation 82: 105–113, 1990b
London GM, Marchais SJ, Safar ME, Genest AF, Guerin AP, et al. Aortic and large artery compliance in end-stage renal failure. Kidney International 37: 137–142, 1990a
Marchais SJ, Boussac I, Guerin AP, Delavaux G, Metivier F, et al. Arteriosclerosis and antihypertensive response to calcium antagonists in end-stage renal failure. Journal of Cardiovascular Pharmacology 18(Suppl. 1): S74–S78, 1991
Meema HE, Oreopoulos DG, Rapoport A. Serum magnesium level and arterial calcification in end-stage renal disease. Kidney International 32: 388–394, 1987
O’Rourke MF. Arterial function in health and disease, pp. 53–132, pp. 185–195, Churchill Livingstone, Edinburgh, 1982
Pickering G. Arteriosclerosis and atherosclerosis: the need for clear thinking. American Journal of Medicine 34: 7–18, 1963
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Marchais, S.J., Guerin, A.P. & London, G.M. Arterial Calcinosis, Chronic Renal Failure and Calcium Antagonism. Drugs 44 (Suppl 1), 119–122 (1992). https://doi.org/10.2165/00003495-199200441-00022
Published:
Issue Date:
DOI: https://doi.org/10.2165/00003495-199200441-00022